Structured treatment interruption in patients infected with HIV: A new approach to therapy?

Drugs

Volumn 62, Issue 2, 2002, Pages 245-253

  Gulick, Roy M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; INTERLEUKIN 2; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

CLINICAL TRIAL; DRUG WITHDRAWAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION CONTROL; REVIEW; RISK ASSESSMENT; STRUCTURED TREATMENT INTERRUPTION; TREATMENT INDICATION; TREATMENT PLANNING; VIREMIA; VIRUS INHIBITION; VIRUS MUTATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036183470     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262020-00001     Document Type: Review

References (30)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Changing patterns of mortality across Europe in patients infected with HIV-1
3. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
4. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
5. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
6. Control of HIV despite the discontinuation of antiretroviral therapy
7. Immune control of HIV-1 after early treatment of acute infection
8. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
9. SSITT: A prospective trial of strategic treatment interruptions in 128 patients
10. Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
11. Antiretroviral treatment interruptions in patients with treatment failure: Analyses from the Frankfurt HIV Cohort
12. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia
13. Response to salvage therapy in patients undergoing a structured treatment interruption
14. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
15. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
16. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia
17. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
18. Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
19. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption
20. HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
21. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
22. Host factors in the pathogenesis of HIV disease: Implications for therapeutic strategies
23. Short-cycle intermittent HAART: A pilot study
24. HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment
25. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
26. Mutation takes no vacation: Can structured treatment interruptions increase the risk of drug-resistant HIV-1?
27. Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
28. Acute HIV syndrome after discontinuation of antiretroviral therapy in a patient treated before seroconversion
29. Retroviral rebound syndrome after cessation of suppressive antiretroviral therapy in three patients with chronic HIV infection
30. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report